IM Cannabis Corp. reported revenue of $13.9 million for the third quarter of 2025, unchanged from the same period in 2024. Gross profit decreased by 13% to $2.7 million, with gross margin also declining to 20% from 23% in Q3 2024. The company recorded a net loss of $3.9 million, compared to a net loss of $1.1 million in Q3 2024, mainly due to a one-time goodwill and intangible asset impairment of $3.1 million. Excluding this impairment, net loss was $0.8 million. Non-IFRS adjusted EBITDA loss was $0.6 million, compared to a loss of $0.2 million in Q3 2024. General and administrative expenses were stable at $2.4 million, while selling and marketing expenses decreased by 7% to $1.4 million. Cash and restricted cash on hand as of September 30, 2025, was $2.3 million. The company noted ongoing regulatory changes in Germany could affect sales, and stated it is assessing new business activities as part of a strategic review. The financial statements include a note on the company's ability to continue as a going concern.